Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJun 5, 2019Sani-Guard-SF Waterless Foam Hand SanitizerCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1317-2019Class IITerminatedJun 5, 2019Mild Health Care Antibacterial Hand SoapCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1316-2019Class IITerminatedJun 5, 2019Antibacterial Hand SoapCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1315-2019Class IITerminatedJun 5, 2019INOFOAM Foaming E-2 Food Handling Wash with .6% PCMXCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1314-2019Class IITerminatedJun 5, 2019INODERM Antiseptic Hand SoapCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1313-2019Class IITerminatedJun 5, 2019Instant Waterless Hand SanitizerCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1312-2019Class IITerminatedJun 5, 2019AQUACIL instant foaming hand sanitizerCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1311-2019Class IITerminatedJun 5, 2019ANTIBACTERIAL Foaming Hand Wash With Moisturizers labeled as Antibacterial Foaming SoapCGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.Inopak Ltd · D-1310-2019Class IITerminatedJun 5, 2019Bevacizumab 2.5 mg/0.1 mLLack of assurance of sterilityAvella of Deer Valley, Inc. Store 38 · D-1308-2019Class ITerminatedMay 29, 2019PromactaCross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.Novartis Pharmaceuticals Corp. · D-1309-2019Class IITerminatedMay 29, 2019Articaine DENTALLabeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2%...Septodont Inc. · D-1307-2019Class IITerminatedMay 29, 2019AmitizaLabeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being...Mallinckrodt Pharmaceuticals · D-1295-2019Class IITerminatedMay 29, 2019AmitizaLabeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being...Mallinckrodt Pharmaceuticals · D-1294-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 25 mg 90 film coated tabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Heritage Pharmaceuticals, Inc. · D-1291-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 100 mg 1000 film coated tabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Heritage Pharmaceuticals, Inc. · D-1290-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 50 mg 90 film coated tabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Heritage Pharmaceuticals, Inc. · D-1289-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 100 mg 90 film coated tabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Heritage Pharmaceuticals, Inc. · D-1288-2019Class IITerminatedMay 29, 2019Losartan Potassium TabletsCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Heritage Pharmaceuticals, Inc. · D-1287-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 100 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Golden State Medical Supply Inc. · D-1286-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 100 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Golden State Medical Supply Inc. · D-1285-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 25 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Golden State Medical Supply Inc. · D-1284-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 25 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Golden State Medical Supply Inc. · D-1283-2019Class IITerminatedMay 29, 2019Losartan Potassium Tablets USP 25 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Golden State Medical Supply Inc. · D-1282-2019Class IITerminatedMay 22, 2019CVS Health Children's Cough & Chest Congestion DM Dextromethorphan HBrCGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1306-2019Class IITerminatedMay 22, 2019DrKids Himasal Natural Nasal Saline Solution with Himalayan SaltCGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1305-2019Class IITerminatedMay 22, 2019CVS Health Children's Nasal Saline Drops With Himalayan Salt Saline Nasal Moisturizer Single-Use 30...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1304-2019Class IITerminatedMay 22, 2019DrKids Children's Natural Cough Syrup English Ivy Leaf Organic Agave Nectar Pre-measured Single-Use 0.17 fl...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1303-2019Class IITerminatedMay 22, 2019CVS Health Children's Cough Syrup English Ivy Leaf Daytime Relief Natural Pineapple Flavor 20 Single-Use 0.08...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1302-2019Class IITerminatedMay 22, 2019DrKids Children's Cough & Chest Congestion DMCGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1301-2019Class IITerminatedMay 22, 2019CVS Health Children's Allergy Relief Liquid Medication Diphenhydramine HCl 12.5 mg/5 mL Oral Solution...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1300-2019Class IITerminatedMay 22, 2019DrKids Children's Pain & Fever Oral Solution Acetaminophen 160 mg/5 mLCGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1299-2019Class IITerminatedMay 22, 2019DrKids Children's Allergy Relief Diphenhydramine HCl 12.5 mg/5 mL AntihistamineCGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1298-2019Class IITerminatedMay 22, 2019CVS Health Children's Mucus Relief Chest Congestion Plus Cough Dextromethorphan HBr Cough Suppressant...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1297-2019Class IITerminatedMay 22, 2019CVS Health Children's Pain & Fever Acetaminophen 160 mg/5 mL Pain reliever/Fever reducer Single-Use Vials...CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.Unipharma, Llc. · D-1296-2019Class ITerminatedMay 22, 2019Titanium 4000Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.D.B.P. Distribution · D-1292-2019Class IITerminatedMay 22, 2019Losartan Potassium Tab. USP 50mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at...Preferred Pharmaceuticals, Inc · D-1281-2019Class IIITerminatedMay 22, 2019Relpax (eletriptan HBr) 40 mgLabeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan...Pfizer Inc. · D-1278-2019Class ITerminatedMay 15, 2019Mycophenolate Mofetil for InjectionPresence of Particulate Matter; glass fragment observed in one vial of reconstituted productPar Pharmaceutical, Inc. · D-1293-2019Class ITerminatedMay 15, 2019FENTANYL Transdermal SystemProduct Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.Alvogen, Inc · D-1277-2019Class IITerminatedMay 15, 2019Ketorolac Tromethamine InjectionLack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of...Sagent Pharmaceuticals Inc · D-1274-2019